NCT00045994View on ClinicalTrials.gov

The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

January 31, 2002

Study Completion Date

June 30, 2003

Conditions
HypertensionHypertrophy, Left Ventricular
Interventions
DRUG

ALT-711

All Listed Sponsors
lead

Synvista Therapeutics, Inc

INDUSTRY

NCT00045994 - The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling | Biotech Hunter | Biotech Hunter